Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
151.8 EUR | +1.10% | +3.94% | +5.31% |
26/04 | Former SAP Executive Board member Kleinemeier to permanently head Merck's Supervisory Board | DP |
26/04 | Transcript : Merck KGaA - Shareholder/Analyst Call |
Business Summary
- solutions and products for scientific and biotechnological research (44.2%);
- pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;
- performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc.
Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Number of employees: 62,908
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Life Science
44.2
%
| 10,380 | 46.7 % | 9,281 | 44.2 % | -10.59% |
Healthcare
38.4
%
| 7,839 | 35.3 % | 8,053 | 38.4 % | +2.73% |
Electronics
17.4
%
| 4,013 | 18.1 % | 3,659 | 17.4 % | -8.82% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
28.2
%
| 6,302 | 28.3 % | 5,911 | 28.2 % | -6.20% |
Europe
21.0
%
| 4,524 | 20.3 % | 4,402 | 21.0 % | -2.70% |
Asia Pacific
19.9
%
| 4,479 | 20.1 % | 4,181 | 19.9 % | -6.65% |
China
11.8
%
| 2,818 | 12.7 % | 2,477 | 11.8 % | -12.10% |
Germany
6.8
%
| 1,532 | 6.9 % | 1,420 | 6.8 % | -7.31% |
Latin America
6.0
%
| 1,175 | 5.3 % | 1,267 | 6.0 % | +7.83% |
Middle East and Africa
2.5
%
| 516 | 2.3 % | 535 | 2.5 % | +3.68% |
Switzerland
2.4
%
| 592 | 2.7 % | 512 | 2.4 % | -13.51% |
North America
1.4
%
| 294 | 1.3 % | 287 | 1.4 % | -2.38% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 13/20/13 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 01/14/01 |
Director of Finance/CFO | 53 | 26/19/26 | |
Laura Matz
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Danny Bar-Zohar
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Constantin Fest
IRC | Investor Relations Contact | - | - |
Jeff White
PRN | Corporate Officer/Principal | - | - |
Andrew Paterson
SAM | Sales & Marketing | - | - |
Corporate Officer/Principal | - | 01/21/01 | |
Hong Chow
PRN | Corporate Officer/Principal | 53 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | - |
Jürgen Glaser
BRD | Director/Board Member | 61 | 01/12/01 |
Gabriele Eismann
BRD | Director/Board Member | 62 | 01/91/01 |
Dietmar Oeter
BRD | Director/Board Member | 57 | 01/95/01 |
Alexander Putz
BRD | Director/Board Member | 47 | 01/85/01 |
Director of Finance/CFO | 53 | 26/19/26 | |
Barbara Lambert
BRD | Director/Board Member | 62 | 11/23/11 |
Sascha Held
BRD | Director/Board Member | - | 26/19/26 |
Anne Lange
BRD | Director/Board Member | - | 26/19/26 |
Daniel Thelen
BRD | Director/Board Member | - | 26/19/26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 305,535,626 | 0 | 0 | 29.71 % |
Stock B | 1 | 129,242,252 | 129,159,619 ( 99.94 %) | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
2,787,509 | 4.65% | 140,016,577 $ | |
PT MERCK TBK 86.65% | 388,194,920 | 86.65% | 97,693,134 $ |
VERA THERAPEUTICS, INC. 3.48% | 1,913,501 | 3.48% | 82,510,163 $ |
PRECIGEN, INC. 8.29% | 20,647,152 | 8.29% | 29,938,370 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. |
Miscellaneous Commercial Services
|
Pharmaceuticals: Major
| |
Ares Trading SA
| |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. |
Medical Specialties
|
AZ Electronic Materials (Japan) KK
AZ Electronic Materials (Japan) KK Chemicals: SpecialtyProcess Industries AZ Electronic Materials (Japan) KK manufactures plastic materials and inorganic chemicals. The company is located in Tokyo, Japan |
Chemicals: Specialty
|
Merck Santé SASU
Merck Santé SASU Pharmaceuticals: MajorHealth Technology Merck Santé SAS manufactures pharmaceutical products. The company is headquartered in Lyon, France. |
Pharmaceuticals: Major
|
Merck Financial Services GmbH
Merck Financial Services GmbH Finance/Rental/LeasingFinance Part of Merck KGaA, Merck Financial Services GmbH provides financing operations and activities. The private company is based in Darmstadt, Germany. The CEOs are Jörg Bermüller, Rando Bruns. The German company was founded in 2007. |
Finance/Rental/Leasing
|
Millipore SAS
Millipore SAS Electronic Equipment/InstrumentsElectronic Technology Founded in 1972, Millipore SAS is a subsidiary of Merck KGaA that provides industrial instruments for measurement. The private company is based in Molsheim, France. |
Electronic Equipment/Instruments
|
Merck Life Science A/S
Merck Life Science A/S Electronic Equipment/InstrumentsElectronic Technology Part of Merck KGaA, Merck Life Science A/S is a Danish company that provides industrial instruments for measurement. The private company is located in Denmark. |
Electronic Equipment/Instruments
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
+3.90% | 1.65B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- MRK Stock
- Company Merck KGaA